Data shows more deaths with Medtronic's AneuRx: FDA
WASHINGTON (Reuters) - New data point to greater deaths in patients receiving Medtronic Inc's AneuRx stent graft system, which treats artery bulges in the abdomen, the Food and Drug Administration said on Tuesday.
<p><img src="http://feeds.reuters.com/~a/Reuters/domesticNews?i=0bp1BA" border="0"></img> (http://feeds.reuters.com/~a/Reuters/domesticNews?a=0bp1BA)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/Reuters/domesticNews?i=piBuFqF" border="0"></img> (http://feeds.reuters.com/~f/Reuters/domesticNews?a=piBuFqF) <img src="http://feeds.reuters.com/~f/Reuters/domesticNews?i=3TeqQCf" border="0"></img> (http://feeds.reuters.com/~f/Reuters/domesticNews?a=3TeqQCf) <img src="http://feeds.reuters.com/~f/Reuters/domesticNews?i=h1Zd2pf" border="0"></img> (http://feeds.reuters.com/~f/Reuters/domesticNews?a=h1Zd2pf)
</div><img src="http://feeds.reuters.com/~r/Reuters/domesticNews/~4/253683999" height="1" width="1"/>
http://feeds.reuters.com/~r/Reuters/domesticNews/~3/253683999/idUSN1818697220080318